1

Biological Medicine

2

Biology, Chemistry and Biochemistry and Biophysical Concepts of Biologics and Biosimilars

3

Biopharmaceutics of Biologics

4

Biosimilar Medicines

5

Biosimilars and Biologics

6

Biosimilars Development in Markets

7

Biosimilars in Hematology and Oncology

8

Challenges in Biosimilars Pharmacovigilance

9

Current Challenges in Developing Biosimilars

10

Digital Health

11

Drug Delivery Systems for Biologics and Biosimilars

12

Frontiers in Biopharmaceutical Development of Biologics and Biosimilars

13

Globalization of Biosimilars

14

Innovative Clinical Approach in Biosimilars

15

Intellectual Property Rights

16

Legislative and Regulatory Pathways for Biosimilars

17

Medical Devices and Diagnostics

18

Monoclonal Antibody Biosimilars

19

Nutrition Economics

20

Pharmacogenomics of Biologics

21

Pharmacokinetics and Pharmacodynamics of Biologics

22

Precision Medicine and Advanced Therapies

23

Rare Diseases

24

Regulatory Updates on Biosimilars

25

The Development of Biologics

26

The Manufacturing and Quality Assurance Process for Biologics and Biosimilars

27

Understanding Variability, Stability, and Immunogenicity of Biosimilars

28

USFDA Approved Biosimilars

29

Vaccines as Biologics in the Era of Pandemic

30

Biologics Biosimilars in Dermatology

31

Treatment of Inflammatory Bowel Disease with Biologics

32

Pharmacoepidemiology

33

Pharmaceutical Medicine and Translational Clinical Research

34

Biosimilars and Interchangeable Biologics

35

Biopharmaceuticals